Genomics Market Analysis and Reports | Spain Conference Series

Market Analysis - Genomics 2018

Genomics Market Analysis and Reports | Spain Conference Series

Market Analysis - Genomics 2018

Today’s Market Study of Genomics in USA | Europe | Middle East | Asia Pacific

USA: Economic development and the abundant availability of funds helped the North American genomics market capture the largest market share in 2011.

Europe: Europe held the second largest market share in 2011 owing to the aggressive government initiatives undertaken by the European Union to fund research studies in genomics.

Asia Pacific: Economic development in emerging countries such as India and China makes Asia the fastest growing region of the market. Furthermore, the fact that the Beijing Genomics Institute is the largest genomic research institute in the world helps the Asian market sustain its growth rate.

Middle East: The genomics market is poised to reach USD 19.99 Billion by 2020, growing at a CAGR of 9.9% during the forecast period of 2015 to 2020.

Glance at Market of Genomics:

The field of genomics has surpassed expectations over the past three decades due to massive changes in technology that allowed researchers to interrogate larger pieces of the human genome.

The modern era of genomics arguably began in the mid-1980s with the development of the polymerase chain reaction (PCR) technique that enabled researchers to characterize the genome at the candidate gene level. In the early 1990s, scientists leveraged semiconductor manufacturing techniques to develop microarrays that enabled large-scale genotyping and gene expression profiling studies. In 2003, at a cost of around $3 billion, the first human genome was completed. Since then, next generation sequencing (NGS) has dramatically decreased in cost, recently breaking the barrier of $1,000 per human genome.

These enabling technologies have not only transformed genomics research, but they also opened the door to clinical genomics (i.e., molecular diagnostics). In the clinic, genomic techniques have revolutionized testing across the areas of infectious disease, cancer and inherited disease by enabling measurement of new analytes, improving analytical performance (e.g., sensitivity) and in some cases providing faster turnaround time compared with traditional testing methods.

We are only at the beginning of the genomics revolution. This Executive Insights presents nine key trends and the enabling technologies that will carry the genomics revolution through 2020.

Market Growth of Genomics:

The global genomics market is estimated to reach USD 22.1 billion by 2020, growing at an expected CAGR of 10.3% from 2014 to 2020. Genomics is a subunit of biology that is concerned with the study of genes and its functions and brings together the function and structure of genomes. Genomics is applied in several fields such as biotechnology, genomic medicine, anthropology, and various other social sciences. It consists of functional genomics, comparative genomics, pharmacogenomics, structural genomics, and epigenomics.

The global genomics market has undergone an increase in its market potential due to technological developments. Adding to it, factors including growing prevalence of fetal disorders such as diabetes and cancer, an increase in partial or full compensation by the government of certain countries add to the market’s growth across the globe.

In 2013, genomics-based diagnostics held the largest share of market revenue at over 35% on account of the occurrence of a considerably larger number of research & development initiatives. However, genomics-based personalized medicine segment is projected to have the highest growth rate, at an anticipated CAGR of over 12%, from 2014 to 2020. The high growth rate of the segment is on account of the growing demand for population-based therapeutic solutions and consequent increase in R&D initiatives.

Target Audience:

Eminent personalities, Directors, CEO, President, Vice-president, Organizations, Associations heads and Professors, Research scientists, Genetics laboratory heads, Post-docs, Students other affiliates related to the area of genetics research, genomics line companies can be as Target Audience

Companies working for Genomics:



Business Type

Genetic Technologies Group

Fitzroy, Australia

Genetic Testing

Gene Works

Hindmarsh, SA, Australia

Custom oligos, next-gen sequencing, product distribution

Ambry Genetics

Aliso Viejo, CA

Genetic Testing

One Lambda (Thermo Fisher)

Canoga Park, CA

Antibody detection, molecular typing

BioSpyder Technologies

Carlsbad, CA

Gene expression profiling

Predictive Biology

Carlsbad, CA

Identifying genetic reasons for drug response

Sure Genomics

Carlsbad, CA

DNA sequencing

Wafer Gen Biosystems (Takara pending)

Fremont, CA

Genome Analysis


Hayward, CA

Genomic tools, research products, molecular diagnostics, NGS

Neo Genomics

Irvine, CA

Genetic & Diagnostic Testing

Proove Biosciences

Irvine, CA

Genetic Tests

Singlera Genomics

La Jolla, CA

Genetic Testing


We are glad to announce the 10th International Conference on Genomics and Pharmacogenomics to be held in Barcelona, Spain from May 21-23, 2018 organized by Conference Series LLC, Spain in collaboration with generous support and cooperation from enthusiastic academicians and editorial Board Members.

Genomics 2018 offers a premier forum to inspire collaboration among biologists and to share trans-disciplinary integrativethinking to unravel the underlying cellular and molecular mechanisms in health, disease and medicine. The theme of the conference is “Explore interdisciplinary approaches of Genetics and Molecular Life Sciences” and topics for discussion are Cancer Genomics, Functional Genomics, Next Generation Sequencing, Biomarkers & Molecular Markers, Pharmacogenomics & Personalized Medicine, Clinical Genomics, Micro RNA Analysis, mRNA Analysis, Bioinformatics in Genomics, Comparative Genomics, Plant Genomics, Personal Genomics, Microbial Genomics and Future trends in Genomics.

As the premier event, we have developed a program with your interests in mind. We have not only increased the number of opportunities for you to network with colleagues from across the world but also introduced more focused sessions that will feature cutting edge presentations, special panel discussions, and livelier interaction with industry leaders and experts.